Jack B. Cowie III, N.Ph.D.


Founder & Chief Executive Officer

 Jack is a dedicated researcher of neuroimmunology, who has committed himself to the eradication of suffering from neurodegeneration.   Jack has familial relationships with both multiple sclerosis and Alzheimer's Disease. 

Jerry De Zutter, Ph.D.


Chief Scientific Officer

 Jerry is a senior scientist, with extensive experience in assay development and signal transduction pathway investigation in neurodegeneration, inflammation and autoimmune diseases, especially amyotrophic lateral sclerosis (ALS). Past positions includes the ALS TDI, Wyeth and Sanofi Genzyme.  

Mike McGurk, Esq, CLP


Chief Legal Officer

 Mike has over 30 years of experience in virtually all aspects of patent law. Working with clients ranging from small startups to large Fortune 100 companies.  Mike has focused his work on biotechnology, pharmaceuticals, chemicals, medical devices, and mechanical technologies.